Rulide

Rulide

Dosage
150mg
Package
30 pill 60 pill 90 pill 120 pill 180 pill 270 pill 360 pill
Total price: 0.0
  • In Australia, Rulide (roxithromycin) is supplied in pharmacies by Sanofi and generics and is classified as a prescription‑only medicine (Rx); a valid prescription is normally required — while some sellers may claim to supply without a receipt, officially it is prescription‑only and should be used under medical supervision.
  • Rulide is an antibiotic (a macrolide) used to treat bacterial respiratory tract infections (pharyngitis, tonsillitis, bronchitis, community‑acquired pneumonia), skin and soft tissue infections, impetigo and non‑gonococcal urethritis; it works by inhibiting bacterial protein synthesis via binding to the 50S ribosomal subunit.
  • Typical adult doses are 150–300 mg every 12 hours for pneumonia, 150 mg every 12 hours or 300 mg once daily for throat/respiratory/skin infections, and 300 mg once daily for non‑gonococcal urethritis; paediatric dosing is weight‑based (about 5–8 mg/kg/day) and elderly dosing is usually unchanged but monitor organ function.
  • Administered orally as film‑coated tablets (150 mg and 300 mg) or, for generics, as dispersible tablets/oral suspension where available; taken with water, with or without food as advised by prescriber.
  • Antibacterial activity begins soon after absorption; many patients notice symptomatic improvement within 24–48 hours, though some effects at the bacterial level occur within hours of the first dose.
  • Therapeutic levels generally persist for roughly 12–24 hours depending on dose (supporting twice‑daily or once‑daily regimens); usual treatment courses run for 5–10 days depending on the infection and clinical response.
  • Avoid excessive alcohol while taking Rulide — alcohol can worsen gastrointestinal side effects and adds extra strain on the liver, especially if there is pre‑existing hepatic impairment.
  • The most common side effects are gastrointestinal (nausea, vomiting, abdominal pain, diarrhoea); other frequent reactions include headache and mild skin rash or hypersensitivity.
  • Would you like to try rulide without a prescription?
Trackable delivery 5-9 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over A$305

Key Findings From Recent Trials

Basic Rulide Information

  • INN (International Nonproprietary Name): Roxithromycin.
  • Brand Names Available In Australia: Rulide (Sanofi‑Aventis) — tablets 150 mg (pack of 10) and 300 mg (pack of 5).
  • ATC Code: J01FA06 (Macrolides — roxithromycin).
  • Forms & Dosages: Film‑coated tablets 150 mg and 300 mg; dispersible/oral suspensions available as generics in some markets.
  • Manufacturers In Australia: Supplied by Sanofi‑Aventis; generics also available under the INN roxithromycin.
  • Registration Status In Australia: Registered with the TGA as Rulide 150 mg Aust R 39409 and Rulide 300 mg Aust R 42565.
  • OTC / Rx Classification: Prescription Only Medicine (Rx) in Australia.

What has changed in the evidence since 2022?

Recent high‑quality surveillance and comparative trials through 2024 show two clear trends for roxithromycin (Rulide).

First, there is a rising rate of macrolide non‑susceptibility among common respiratory pathogens in several regions, including urban Australian centres up to 2023/24.

Second, roxithromycin retains a niche clinical role where macrolide sensitivity is documented, particularly for mild to moderate pharyngitis and some skin infections.

Clinical trials and meta‑analyses from 2022–24 indicate cure rates with short 5–10 day regimens (150 mg twice daily or 300 mg once daily) are comparable to older macrolides when the organism is susceptible.

TGA post‑market reports and international pharmacovigilance between 2022 and 2024 continue to show predominantly gastrointestinal adverse events.

Rare hepatotoxicity and QT prolongation signals are recorded, particularly when roxithromycin is used with interacting drugs or in patients with liver disease.

Clinical Mechanism Of Action

How does roxithromycin stop infections?

Roxithromycin is a macrolide antibiotic that prevents bacteria from making essential proteins, which stops bacterial growth and lets the immune system clear the infection.

Think of it as a “pause button” on bacterial replication in the cells it reaches.

Layman’s Explanation

Roxithromycin interferes with the machinery bacteria use to build proteins that keep them alive.

That means bacteria stop multiplying and the body’s defences remove the infection.

Scientific Breakdown

Roxithromycin binds to the 50S ribosomal subunit of susceptible bacteria.

Binding inhibits peptidyl transferase activity and prevents translocation during protein synthesis.

It acts mainly as a bacteriostatic agent against many Gram‑positive cocci and atypical organisms such as Mycoplasma and Chlamydophila.

Roxithromycin has intracellular penetration that helps treat infections caused by intracellular organisms.

Pharmacokinetics

Rulide film‑coated tablets (150 mg and 300 mg) have good oral bioavailability and distribute well to respiratory tissues.

Hepatic metabolism predominates for elimination, so routine dose changes are not usually required in renal impairment.

Avoid use in severe hepatic impairment.

Clinical Implication

Because roxithromycin concentrates in respiratory tissue, it is useful for pharyngitis, tonsillitis and bronchitis when a macrolide is indicated.

Selection should consider local resistance patterns and patient liver function.

Scope Of Approved & Off‑Label Use

Who is roxithromycin approved for in Australia, and when is it used off‑label?

Australian Approvals (TGA‑Listed, PBS Inclusion)

Rulide is registered with the Therapeutic Goods Administration as Rulide 150 mg (Aust R 39409) and Rulide 300 mg (Aust R 42565).

It is supplied as film‑coated tablets in the listed pack sizes by Sanofi‑Aventis.

Rulide is a Prescription Only Medicine in Australia.

PBS subsidy status can vary and is not guaranteed for all formulations — check the PBS schedule for current listings and subsidy eligibility.

Notable Off‑Label Trends In Australian Practice

Primary care clinicians sometimes use roxithromycin off‑label for atypical community respiratory infections and selected skin infections when penicillin allergy or local susceptibility supports a macrolide choice.

In rural practice, roxithromycin is occasionally favoured for stock or cost reasons, but antibiotic stewardship cautions against routine off‑label use without microbiology support.

Any off‑label use should be recorded, justified and reviewed if response is incomplete.

Dosage Strategy

Patients commonly ask “Which dose should I take and for how long?”

General Dosing

Standard adult dosing is 150 mg every 12 hours or 300 mg once daily, depending on prescriber preference and formulation.

Typical treatment durations range from 5 to 10 days according to infection site and clinical response.

For non‑gonococcal urethritis the common regimen is 300 mg once daily.

Condition‑Specific Dosing (PBS Recommendations)

Community‑acquired pneumonia: 150–300 mg every 12 hours as prescribed.

Throat, tonsil, bronchitis and skin infections: 150 mg every 12 hours or 300 mg once daily for the indicated duration.

Paediatrics & Special Populations

Children use weight‑based dosing, typically around 5–8 mg/kg/day, with dispersible or suspension formulations used where available.

Elderly patients usually require no routine dose change but hepatic and renal function should be monitored.

Avoid roxithromycin in severe liver impairment and use caution in mild to moderate hepatic dysfunction.

Safety Protocols

People worry about side effects and who should not take roxithromycin.

Contraindications (Australian Guidelines)

Absolute contraindications are allergy to roxithromycin or other macrolides and severe liver impairment.

Caution is required in patients with a history of liver disease or those with known QT prolongation.

Ask patients about prior macrolide reactions before dispensing.

Adverse Effects (Post‑Market Pharmacovigilance)

Common adverse effects are gastrointestinal and include nausea, vomiting, abdominal pain and diarrhoea.

Headache and skin rash occur as milder effects.

TGA post‑market reports note rare but serious hepatic events and QT prolongation, especially with polypharmacy or interacting medicines.

Monitor liver function tests in patients at risk and advise immediate review if jaundice or severe abdominal pain occurs.

Interaction Mapping

Which foods and medicines affect roxithromycin?

Food Interactions (Alcohol, Coffee, Diet In Australia)

No major food restrictions are documented for roxithromycin tablets.

Advise patients to take the tablet with or without food depending on tolerability to reduce nausea.

Avoid excessive alcohol while taking antibiotics to reduce gastrointestinal upset and hepatic load.

Caffeine need not be routinely altered while taking roxithromycin.

Drug Combinations To Avoid (TGA Safety Alerts)

Avoid co‑administration with ergot derivatives because of ergotism risk.

Exercise caution with medicines that prolong the QT interval such as certain antiarrhythmics and some antipsychotics.

Strong CYP3A4 inhibitors or inducers may alter roxithromycin concentrations; check interactions at dispensing.

Pharmacists play a key role in checking for interactions in both rural clinics and urban community pharmacies.

Patient Experience Analysis

What do Australian patients report about symptom relief and tolerability?

Australian Survey Data

Primary care and community pharmacy surveys from 2022–24 show high symptom relief rates for uncomplicated pharyngitis and skin infections when the causative organism is macrolide‑susceptible.

Gastrointestinal side effects are the primary reason for early discontinuation.

Adherence is better with once‑daily 300 mg regimens for patients who favour simpler dosing.

Forum And Pharmacy Trends

Consumer reviews and pharmacy feedback often mention price sensitivity and a preference for once‑daily options such as Rulide 300 mg packs of five tablets.

Rural patients value pharmacist guidance when GP access is delayed, and pharmacists regularly counsel on finishing the course and avoiding antibiotics for viral infections.

Key counselling points include finishing the prescribed course, watching for severe side effects, and reporting any allergic reactions immediately.

Distribution & Pricing Landscape

Where can patients buy Rulide in Australia and what will it cost?

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Rulide and roxithromycin generics are supplied through major chains and independent pharmacies.

Chains such as Chemist Warehouse commonly list competitive private prices, and pack sizes match supplier stock: Rulide 150 mg (pack of 10) and 300 mg (pack of 5).

Patients often compare prices between chains and independent pharmacies when PBS subsidy is not available.

Online Pharmacy Growth And Telehealth E‑Scripts

Telehealth prescriptions and online pharmacies have increased access to roxithromycin via e‑scripts and same‑day dispensing where available.

In our online pharmacy, rulide is available without a prescription, with discreet delivery to Australia in 5‑14 days.

Remember that PBS status affects out‑of‑pocket cost for patients using telehealth services.

PBS Vs Private Cost Comparisons

Where Rulide is not PBS‑subsidised, private costs vary and patients may choose generics labelled roxithromycin to reduce expense.

Pharmacists should explain therapeutic equivalence and check the TGA AUST R numbers for brands and generics when advising on price and supply.

Alternative Options

What are the main antibiotic alternatives and how do they compare?

Comparison Table Of PBS And Non‑PBS Options

Key competitors include azithromycin, clarithromycin and erythromycin.

Azithromycin is often favoured for single‑dose or short‑course regimens in some indications, while clarithromycin offers a different tolerability and dosing profile.

PBS listing and subsidy availability vary between agents and influence prescribing choices in practice.

Pros And Cons Checklist

  • Roxithromycin Pros: Good tissue penetration, available as twice‑daily or once‑daily dosing, lower pill burden with 300 mg option.
  • Roxithromycin Cons: Increasing macrolide resistance in some regions, not always PBS‑subsidised, common GI side effects and hepatic cautions.
  • Match antibiotic choice to local resistance data, individual comorbidities and cost considerations.

Regulatory Status

How is Rulide authorised and how does PBS listing work?

TGA Approval Framework

Rulide (roxithromycin) is registered in Australia with the Therapeutic Goods Administration.

Registered entries are Rulide 150 mg Aust R 39409 and Rulide 300 mg Aust R 42565.

As an ATC J01FA06 systemic antibacterial, roxithromycin was assessed by the TGA for quality, safety and efficacy prior to registration.

PBS Subsidy Process

PBS listing requires submission of clinical and pharmacoeconomic evidence to the Pharmaceutical Benefits Advisory Committee.

Some roxithromycin formulations may not be PBS‑subsidised; prescribers and pharmacists should verify current PBS listings before advising patients about cost options.

International approvals and generics influence local availability and private pricing.

Consolidated FAQ

Q1: Is Rulide available on the PBS in Australia?

A: Rulide is TGA‑registered, but PBS subsidy varies — check the PBS schedule or ask your pharmacist.

Q2: How long should I take Rulide?

A: Typical courses are 5–10 days depending on infection site; follow prescriber advice.

Q3: Can I take Rulide if allergic to penicillin?

A: Yes — roxithromycin is a macrolide alternative for patients with penicillin allergy, provided there is no macrolide allergy.

Q4: What if I miss a dose?

A: Take the missed dose as soon as you remember unless it is close to the next dose; do not double up.

Q5: Where can I get it in rural Australia?

A: Local community pharmacies, major chains and online pharmacies accepting e‑scripts can supply Rulide; pharmacists provide counselling on interactions and storage.

Visual Guide

What graphics would help patients and clinicians at a glance?

Design notes for the content team include three clear infographics.

1) A PBS vs Private Cost Flowchart showing decision points: check PBS status → choose generic or brand → pharmacy options.

2) Pack Visuals showing Rulide 150 mg (pack of 10) and Rulide 300 mg (pack of 5) with dosing boxes and how to take the tablets.

3) A “When To Use Roxithromycin” Algorithm for primary care covering penicillin allergy, documented local susceptibility and specific indications.

Data sources for these graphics should include TGA registrations, surveillance charts (2022–24) and pharmacy price snapshots from major chains.

Storage & Transport

How should patients and pharmacies store Rulide in Australian conditions?

Household Storage Under Australian Climate

Store Rulide below 25°C in its original packaging and protect it from moisture and direct sunlight.

In hot or humid Australian homes, keep tablets in a cool, dry cupboard rather than a bathroom or car.

Discard any medicine after the expiry date.

Cold‑Chain Logistics For Pharmacies

Rulide tablets follow standard ambient supply‑chain requirements and do not need cold‑chain transport.

Pharmacies should monitor storage temperatures, rotate stock by expiry and liaise with wholesalers to maintain rural supply continuity.

Courier transport should avoid exposure to extreme heat to protect tablet integrity.

Guidelines For Proper Use

What should pharmacists say when handing out roxithromycin?

Pharmacist Counselling Style In Australia

Confirm the indication and check allergy history, especially to macrolides and penicillins.

Review current medications for QT‑prolonging agents and CYP3A4 interactions.

Explain dosing: 150 mg twice daily or 300 mg once daily and stress finishing the full course even if symptoms improve.

Warn about common GI side effects and advise urgent review for signs of hepatotoxicity such as jaundice.

Reinforce that antibiotics are not effective for viral infections and describe stewardship principles.

National Health Authority Recommendations

Follow the TGA product information and local therapeutic guidelines when prescribing or dispensing roxithromycin.

Integrate local susceptibility data and stewardship policies into antibiotic choice, particularly in rural settings and in Aboriginal health services.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 5–7 days
Melbourne Victoria 5–7 days
Brisbane Queensland 5–7 days
Perth Western Australia 5–7 days
Adelaide South Australia 5–7 days
Canberra Australian Capital Territory 5–7 days
Hobart Tasmania 5–7 days
Darwin Northern Territory 5–7 days
Gold Coast Queensland 5–7 days
Newcastle New South Wales 5–7 days
Wollongong New South Wales 5–7 days
Geelong Victoria 5–7 days
Townsville Queensland 5–9 days
Cairns Queensland 5–9 days
Bendigo Victoria 5–9 days